We are live on ! Find out more
MD icon

Pediatrix Medical

205 hedge funds and large institutions have $1.04B invested in Pediatrix Medical in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 73 increasing their positions, 78 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $405K | Put options by funds: $155K

0.3% less ownership

Funds ownership: 98.04%97.74% (-0.3%)

6% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 78

5% less funds holding

Funds holding: 215205 (-10)

10% less capital invested

Capital invested by funds: $1.16B → $1.04B (-$116M)

33% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 30

Holders
205
Holders Change
-10
Holders Change %
-4.65%
% of All Funds
3.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
73
Reduced
78
Closed
30
Calls
$405K
Puts
$155K
Net Calls
+$250K
Net Calls Change
-$125K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$165M -$6.14M -447,270 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$132M +$317K +23,111 +0.2%
Lazard Asset Management
3
Lazard Asset Management
New York
$105M +$627K +45,698 +0.6%
AllianceBernstein
4
AllianceBernstein
Tennessee
$97.4M -$11.3M -826,334 -10%
EARNEST Partners
5
EARNEST Partners
Georgia
$64.8M -$2.95M -215,045 -4%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$55.3M +$3.73M +271,677 +7%
State Street
7
State Street
Massachusetts
$41.3M -$703K -51,216 -2%
SBH
8
Segall Bryant & Hamill
Illinois
$22.4M +$4.65M +339,013 +24%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$22.1M +$101K +7,375 +0.4%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$21.6M +$928K +67,644 +4%
Charles Schwab
11
Charles Schwab
California
$18.9M +$785K +57,193 +4%
Pacer Advisors
12
Pacer Advisors
Pennsylvania
$18.1M +$19.6M +1,425,901 New
RRAM
13
River Road Asset Management
Kentucky
$12.3M -$8.43M -613,941 -39%
Northern Trust
14
Northern Trust
Illinois
$10.8M -$4.12K -300 -0%
ACB
15
Aristotle Capital Boston
Massachusetts
$10.6M +$70.4K +5,132 +0.6%
PCM
16
Palisade Capital Management
New Jersey
$10.5M +$170K +12,352 +2%
Morgan Stanley
17
Morgan Stanley
New York
$9.93M -$2.24M -163,016 -17%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$9.66M -$412K -30,002 -4%
Citadel Advisors
19
Citadel Advisors
Florida
$9.41M -$1.9M -138,775 -16%
ICM
20
Invenomic Capital Management
Massachusetts
$9.06M +$4.29M +312,778 +78%
Goldman Sachs
21
Goldman Sachs
New York
$9.06M -$500K -36,415 -5%
Invesco
22
Invesco
Georgia
$8.96M +$232K +16,875 +2%
Norges Bank
23
Norges Bank
Norway
$8.74M -$388K -28,249 -4%
Allianz Asset Management
24
Allianz Asset Management
Germany
$8.16M +$705K +51,393 +9%
ACH
25
ArrowMark Colorado Holdings
Colorado
$7.85M -$575K -41,901 -6%

MD Hedge Fund Activity: Q3 2023 in Review

205 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2023, worth a combined $1.04B — down 10% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of MD and 20 opened new positions — a net loss of 10 holders — while 78 trimmed existing stakes and 73 added.

The largest buyer was Pacer Advisors, opening a new position worth an estimated $19.6M. The largest seller was AllianceBernstein, cutting an estimated $11.3M.

  • 205 institutional investors held Pediatrix Medical (MD) as of Q3 2023, down from 215 in Q2 2023.
  • Funds reported $1.04B of Pediatrix Medical stock for Q3 2023, down 10% quarter-over-quarter.
  • 20 funds opened new Pediatrix Medical positions in Q3 2023 and 30 closed out, a net change of -10 holders.
  • The largest Pediatrix Medical buyer in Q3 2023 was Pacer Advisors, an estimated $19.6M added.
  • The largest Pediatrix Medical seller in Q3 2023 was AllianceBernstein, an estimated $11.3M sold.

Based on aggregated 13F filings for Q3 2023.